Kaposi Sarcoma — HHV-8 Skin Lesions Explained

What Is Kaposi Sarcoma?

Kaposi sarcoma is a cancer that grows from the endothelial cells lining small blood vessels and lymphatic vessels. As those abnormal vessel-forming cells multiply, they create the disease's signature finding — kaposi sarcoma skin lesions: flat patches, slightly raised plaques, or firmer nodules in shades of purple, red-brown, blue or violaceous brown. They are usually painless, can appear in more than one place at once, and most commonly involve the lower legs, feet, ankles, face and the lining of the mouth. Because the cancer arises in vessels rather than as one solid mass, it behaves very differently from the deep limb lumps described on our sarcoma — overview hub.

The single most important fact about Kaposi sarcoma is that it is caused by a virus: human herpesvirus 8 (HHV-8), also known as Kaposi-sarcoma-associated herpesvirus (KSHV). Many people carry HHV-8 quietly for life and never develop any cancer. The virus only causes Kaposi sarcoma when the immune system that normally keeps it in check becomes weakened — by HIV infection, by anti-rejection drugs after a transplant, or simply by the gradual immune decline of old age. This is why doctors describe an hhv8 sarcoma as a disease of the virus and the immune system together, and why the first treatment question is always: why has this person's immunity dropped?

Kaposi sarcoma is one of several vascular sarcomas. It is sometimes confused with angiosarcoma, another blood-vessel cancer — but the two are entirely different: angiosarcoma is an aggressive, fast-spreading tumour unrelated to any virus, whereas Kaposi sarcoma is HHV-8-driven, usually more indolent, and frequently improves when immune function is restored.

The Four Clinical Types of Kaposi Sarcoma

Doctors group Kaposi sarcoma into four forms. They share the same HHV-8 cause and the same purple lesions under the microscope, but they affect different people, behave differently, and — most importantly — are treated differently. Identifying which type you have is the first step a specialist takes.

In India, the picture is mixed. Classic Kaposi sarcoma is uncommon, the AIDS-related form follows the HIV burden in the community, and transplant-related cases are seen at centres with active organ-transplant programmes. Whatever the type, the same rule applies: a purple skin lesion should be biopsied and the underlying immune state assessed before any treatment is chosen. If you are unsure where to begin, our sarcoma treatment in Hyderabad page explains how CION coordinates that work-up.

Kaposi Sarcoma Symptoms — and When a Purple Patch Matters

The earliest sign is usually a painless purple, brown-red or bluish mark on the skin that does not fade like a bruise and slowly grows or multiplies. Over weeks to months a flat patch can thicken into a raised plaque and then into a firm nodule. Several lesions may appear along the same area, and they have a tendency to follow skin lines on the legs and feet.

Beyond the skin, Kaposi sarcoma can affect other tissues, and these features need prompt specialist attention:

• Leg swelling (lymphoedema) when lesions block lymph drainage in the lower limb
• Lesions in the mouth or on the palate, which can bleed, ulcerate or make eating uncomfortable
• Cough or breathlessness if disease involves the lungs — a warning sign that needs urgent imaging
• Gastrointestinal bleeding or anaemia from lesions in the stomach or bowel

How Kaposi Sarcoma Is Diagnosed and Staged

Because a purple lesion can be so many things, diagnosis depends on tissue, not appearance. At CION the work-up follows a clear sequence so that the right treatment is matched to the right type of disease.

Step 1 — Skin Biopsy

A small sample of a representative lesion is taken under local anaesthetic. Under the microscope, Kaposi sarcoma shows characteristic spindle cells forming slit-like vascular channels filled with red cells — a pattern a specialist sarcoma pathologist recognises readily but which can be missed in an early, flat patch.

Step 2 — HHV-8 (LANA-1) Confirmation

The diagnosis is locked in with immunostaining for the HHV-8 latent nuclear antigen (LANA-1). A positive LANA-1 stain confirms the lesion is truly Kaposi sarcoma and distinguishes it from look-alike vascular tumours. This single test is the difference between a confident diagnosis and an educated guess.

Step 3 — Immune Status and Cause

Every patient is tested for HIV, and if positive, the CD4 count and viral load are measured because they directly shape the treatment plan. In transplant patients, the immunosuppressant regimen is reviewed. Establishing why the immune system is weak is as important as confirming the cancer itself.

Step 4 — Checking for Internal Disease

Where symptoms suggest it, the chest, abdomen and gut are assessed — a chest X-ray or CT for lung involvement, and endoscopy if there are signs of gastrointestinal bleeding. Staging then describes the extent of skin, lymph node and internal disease, and the patient's overall immune state, which together guide whether local or systemic treatment is needed.

How Kaposi Sarcoma Is Treated

Treatment is matched to the type, the extent of disease, and — above all — the immune system. For most patients the first and most powerful step is to restore immunity; local and systemic therapies are added when needed.

Notice what is not on this list: the wide local excision used for deep limb sarcomas. Because Kaposi sarcoma is multifocal and virus-driven, cutting out every lesion is neither practical nor curative — new lesions simply appear elsewhere while immunity stays low. That is the key difference between Kaposi sarcoma and a localised soft tissue tumour, and why an experienced oncology team, not a single surgeon, should direct the plan. You can compare the surgery-led pathway for other sarcomas on our sarcoma treatment in Hyderabad page.

Prognosis and What to Expect

The outlook for Kaposi sarcoma is usually better than for most other sarcomas, and it depends far more on the immune system than on the lesions themselves. Classic Kaposi sarcoma in older adults is typically slow and chronic — many patients live for years with stable disease that needs only occasional local treatment. AIDS-related Kaposi sarcoma has been transformed by modern HIV therapy: when antiretrovirals restore the CD4 count, lesions frequently fade and the cancer comes under durable control. Transplant-related disease often regresses once immunosuppression is adjusted.

The disease becomes more serious when it is widespread, when it involves the lungs or gut, or when the immune system cannot be rebuilt. Even then, systemic chemotherapy can control symptoms and slow progression. Because Kaposi sarcoma is a chronic, relapsing condition, the goal is long-term control with the least possible toxicity — which means regular review of both the lesions and the underlying immune state, not a single course of treatment and discharge.

Indicative Cost in Hyderabad

Costs are indicative. A personalised estimate is provided after your CION consultation. EMI options and cashless support through major TPAs, Aarogyasri, CGHS, ECHS & ESI are available for eligible patients.

Why Patients Choose CION for Kaposi Sarcoma Care

Kaposi sarcoma sits at the meeting point of oncology, infectious disease and immune medicine. Here is why patients trust CION to coordinate that care correctly.

Don't Self-Diagnose a Purple Lesion

A growing purple skin lesion deserves a biopsy and an immune work-up, not a wait-and-watch. If you suspect Kaposi sarcoma — or already have a report mentioning HHV-8 — talk to our oncology team and get a clear, type-specific plan.